Nexalis Therapeutics Limited (ASX:NX1)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
At close: Mar 9, 2026
Nexalis Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.44 | 0.19 | 0.72 | 2.13 | 2.8 | Upgrade
|
| Cash & Short-Term Investments | 0.44 | 0.19 | 0.72 | 2.13 | 2.8 | Upgrade
|
| Cash Growth | 124.15% | -72.77% | -66.45% | -23.90% | 63.04% | Upgrade
|
| Accounts Receivable | 0.69 | - | - | - | - | Upgrade
|
| Other Receivables | - | 0.45 | 0.8 | 0.03 | 0.02 | Upgrade
|
| Receivables | 0.69 | 0.45 | 0.8 | 0.03 | 0.02 | Upgrade
|
| Inventory | - | - | - | - | 0.02 | Upgrade
|
| Prepaid Expenses | 0.08 | 0.07 | 0.06 | 0.08 | 0.06 | Upgrade
|
| Other Current Assets | - | - | - | - | 0 | Upgrade
|
| Total Current Assets | 1.21 | 0.71 | 1.58 | 2.24 | 2.91 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.01 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.01 | 0.01 | Upgrade
|
| Total Assets | 1.21 | 0.71 | 1.58 | 2.26 | 2.93 | Upgrade
|
| Accounts Payable | 1.64 | 0.57 | 0.18 | 0.12 | 0.07 | Upgrade
|
| Accrued Expenses | 0 | - | 0 | 0 | - | Upgrade
|
| Short-Term Debt | 0.43 | 0.03 | 0.56 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.02 | Upgrade
|
| Other Current Liabilities | - | 0.17 | 0.17 | 0.23 | 0.16 | Upgrade
|
| Total Current Liabilities | 2.07 | 0.78 | 0.91 | 0.36 | 0.25 | Upgrade
|
| Long-Term Debt | 0.32 | - | - | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 0 | 0 | 0 | - | - | Upgrade
|
| Total Liabilities | 2.38 | 0.78 | 0.91 | 0.36 | 0.25 | Upgrade
|
| Common Stock | 15.15 | 14.53 | 14.08 | 13.93 | 12.9 | Upgrade
|
| Retained Earnings | -16.21 | -14.38 | -13.17 | -11.73 | -9.25 | Upgrade
|
| Comprehensive Income & Other | -0.12 | -0.21 | -0.24 | -0.3 | -0.97 | Upgrade
|
| Shareholders' Equity | -1.18 | -0.06 | 0.67 | 1.9 | 2.68 | Upgrade
|
| Total Liabilities & Equity | 1.21 | 0.71 | 1.58 | 2.26 | 2.93 | Upgrade
|
| Total Debt | 0.74 | 0.03 | 0.56 | - | - | Upgrade
|
| Net Cash (Debt) | -0.3 | 0.16 | 0.16 | 2.13 | 2.8 | Upgrade
|
| Net Cash Growth | - | 3.41% | -92.71% | -23.90% | 63.04% | Upgrade
|
| Net Cash Per Share | -0.00 | 0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 217.98 | 213.45 | 189.77 | 187.27 | 168.47 | Upgrade
|
| Total Common Shares Outstanding | 217.98 | 213.45 | 189.77 | 187.27 | 168.47 | Upgrade
|
| Working Capital | -0.86 | -0.06 | 0.67 | 1.89 | 2.65 | Upgrade
|
| Book Value Per Share | -0.01 | -0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Tangible Book Value | -1.18 | -0.06 | 0.67 | 1.89 | 2.66 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.